Global Gonadotropin-releasing Hormone Agonist Market Research Report 2023
Gonadotropin-releasing Hormone is a releasing hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary.
According to QYResearch’s new survey, global Gonadotropin-releasing Hormone Agonist market is projected to reach US$ 4576.3 million in 2029, increasing from US$ 4152 million in 2022, with the CAGR of 1.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gonadotropin-releasing Hormone Agonist market research.
The Luteinizing Hormone-releasing Hormone (LHRH) Analogs market is primarily driven by the demand for hormone therapy options in managing hormone-dependent conditions such as prostate cancer and certain gynecological disorders. LHRH analogs, also known as LHRH agonists, are medications that suppress the release of sex hormones by altering the signaling of the hypothalamus-pituitary-gonadal axis. The increasing prevalence of hormone-related diseases, coupled with advancements in oncology and reproductive medicine, contributes to market growth. Moreover, the demonstrated benefits of LHRH analogs in reducing hormone levels and controlling tumor growth further propel adoption. However, challenges include optimizing treatment regimens for specific conditions and addressing potential side effects such as hormonal imbalances and bone density loss. Navigating personalized treatment plans, managing patient expectations, and ensuring long-term safety and efficacy are ongoing concerns. The market's success relies on continuous research in endocrinology and oncology, collaborations between pharmaceutical manufacturers and healthcare providers, and comprehensive patient education on the benefits and potential risks of LHRH analog treatments while addressing the evolving challenges associated with hormone-related diseases and treatment customization.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gonadotropin-releasing Hormone Agonist market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Gonadotropin-releasing Hormone Agonist market is projected to reach US$ 4576.3 million in 2029, increasing from US$ 4152 million in 2022, with the CAGR of 1.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gonadotropin-releasing Hormone Agonist market research.
The Luteinizing Hormone-releasing Hormone (LHRH) Analogs market is primarily driven by the demand for hormone therapy options in managing hormone-dependent conditions such as prostate cancer and certain gynecological disorders. LHRH analogs, also known as LHRH agonists, are medications that suppress the release of sex hormones by altering the signaling of the hypothalamus-pituitary-gonadal axis. The increasing prevalence of hormone-related diseases, coupled with advancements in oncology and reproductive medicine, contributes to market growth. Moreover, the demonstrated benefits of LHRH analogs in reducing hormone levels and controlling tumor growth further propel adoption. However, challenges include optimizing treatment regimens for specific conditions and addressing potential side effects such as hormonal imbalances and bone density loss. Navigating personalized treatment plans, managing patient expectations, and ensuring long-term safety and efficacy are ongoing concerns. The market's success relies on continuous research in endocrinology and oncology, collaborations between pharmaceutical manufacturers and healthcare providers, and comprehensive patient education on the benefits and potential risks of LHRH analog treatments while addressing the evolving challenges associated with hormone-related diseases and treatment customization.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gonadotropin-releasing Hormone Agonist market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- AbbVie
- AstraZeneca
- Ferring
- TerSera Therapeutics
- Takeda
- LIVZON
- Ipsen
- Sanofi
- Endo
- Leuprorelin
- Goserelin
- Taltirelin
- Histrelin
- Other
- Hospital
- Pharmacy
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 GONADOTROPIN-RELEASING HORMONE AGONIST MARKET OVERVIEW
1.1 Product Overview and Scope of Gonadotropin-releasing Hormone Agonist
1.2 Gonadotropin-releasing Hormone Agonist Segment by Type
1.2.1 Global Gonadotropin-releasing Hormone Agonist Market Value Comparison by Type (2023-2029)
1.2.2 Leuprorelin
1.2.3 Goserelin
1.2.4 Taltirelin
1.2.5 Histrelin
1.2.6 Other
1.3 Gonadotropin-releasing Hormone Agonist Segment by Application
1.3.1 Global Gonadotropin-releasing Hormone Agonist Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Gonadotropin-releasing Hormone Agonist Market Size Estimates and Forecasts
1.4.1 Global Gonadotropin-releasing Hormone Agonist Revenue 2018-2029
1.4.2 Global Gonadotropin-releasing Hormone Agonist Sales 2018-2029
1.4.3 Global Gonadotropin-releasing Hormone Agonist Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 GONADOTROPIN-RELEASING HORMONE AGONIST MARKET COMPETITION BY MANUFACTURERS
2.1 Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Manufacturers (2018-2023)
2.2 Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Gonadotropin-releasing Hormone Agonist Average Price by Manufacturers (2018-2023)
2.4 Global Gonadotropin-releasing Hormone Agonist Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist, Product Type & Application
2.7 Gonadotropin-releasing Hormone Agonist Market Competitive Situation and Trends
2.7.1 Gonadotropin-releasing Hormone Agonist Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gonadotropin-releasing Hormone Agonist Players Market Share by Revenue
2.7.3 Global Gonadotropin-releasing Hormone Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 GONADOTROPIN-RELEASING HORMONE AGONIST RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Gonadotropin-releasing Hormone Agonist Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gonadotropin-releasing Hormone Agonist Global Gonadotropin-releasing Hormone Agonist Sales by Region: 2018-2029
3.2.1 Global Gonadotropin-releasing Hormone Agonist Sales by Region: 2018-2023
3.2.2 Global Gonadotropin-releasing Hormone Agonist Sales by Region: 2024-2029
3.3 Global Gonadotropin-releasing Hormone Agonist Global Gonadotropin-releasing Hormone Agonist Revenue by Region: 2018-2029
3.3.1 Global Gonadotropin-releasing Hormone Agonist Revenue by Region: 2018-2023
3.3.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Region: 2024-2029
3.4 North America Gonadotropin-releasing Hormone Agonist Market Facts & Figures by Country
3.4.1 North America Gonadotropin-releasing Hormone Agonist Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2029)
3.4.3 North America Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gonadotropin-releasing Hormone Agonist Market Facts & Figures by Country
3.5.1 Europe Gonadotropin-releasing Hormone Agonist Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2029)
3.5.3 Europe Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gonadotropin-releasing Hormone Agonist Market Facts & Figures by Country
3.6.1 Asia Pacific Gonadotropin-releasing Hormone Agonist Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2029)
3.6.3 Asia Pacific Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gonadotropin-releasing Hormone Agonist Market Facts & Figures by Country
3.7.1 Latin America Gonadotropin-releasing Hormone Agonist Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2029)
3.7.3 Latin America Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gonadotropin-releasing Hormone Agonist Market Facts & Figures by Country
3.8.1 Middle East and Africa Gonadotropin-releasing Hormone Agonist Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Gonadotropin-releasing Hormone Agonist Sales by Type (2018-2029)
4.1.1 Global Gonadotropin-releasing Hormone Agonist Sales by Type (2018-2023)
4.1.2 Global Gonadotropin-releasing Hormone Agonist Sales by Type (2024-2029)
4.1.3 Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Type (2018-2029)
4.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Type (2018-2029)
4.2.1 Global Gonadotropin-releasing Hormone Agonist Revenue by Type (2018-2023)
4.2.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Type (2024-2029)
4.2.3 Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Type (2018-2029)
4.3 Global Gonadotropin-releasing Hormone Agonist Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Gonadotropin-releasing Hormone Agonist Sales by Application (2018-2029)
5.1.1 Global Gonadotropin-releasing Hormone Agonist Sales by Application (2018-2023)
5.1.2 Global Gonadotropin-releasing Hormone Agonist Sales by Application (2024-2029)
5.1.3 Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Application (2018-2029)
5.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Application (2018-2029)
5.2.1 Global Gonadotropin-releasing Hormone Agonist Revenue by Application (2018-2023)
5.2.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Application (2024-2029)
5.2.3 Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Application (2018-2029)
5.3 Global Gonadotropin-releasing Hormone Agonist Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Gonadotropin-releasing Hormone Agonist Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Gonadotropin-releasing Hormone Agonist Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Ferring
6.3.1 Ferring Corporation Information
6.3.2 Ferring Description and Business Overview
6.3.3 Ferring Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ferring Gonadotropin-releasing Hormone Agonist Product Portfolio
6.3.5 Ferring Recent Developments/Updates
6.4 TerSera Therapeutics
6.4.1 TerSera Therapeutics Corporation Information
6.4.2 TerSera Therapeutics Description and Business Overview
6.4.3 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.4.4 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Product Portfolio
6.4.5 TerSera Therapeutics Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Corporation Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Takeda Gonadotropin-releasing Hormone Agonist Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 LIVZON
6.6.1 LIVZON Corporation Information
6.6.2 LIVZON Description and Business Overview
6.6.3 LIVZON Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.6.4 LIVZON Gonadotropin-releasing Hormone Agonist Product Portfolio
6.6.5 LIVZON Recent Developments/Updates
6.7 Ipsen
6.6.1 Ipsen Corporation Information
6.6.2 Ipsen Description and Business Overview
6.6.3 Ipsen Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ipsen Gonadotropin-releasing Hormone Agonist Product Portfolio
6.7.5 Ipsen Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sanofi Gonadotropin-releasing Hormone Agonist Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Endo
6.9.1 Endo Corporation Information
6.9.2 Endo Description and Business Overview
6.9.3 Endo Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Endo Gonadotropin-releasing Hormone Agonist Product Portfolio
6.9.5 Endo Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Gonadotropin-releasing Hormone Agonist Industry Chain Analysis
7.2 Gonadotropin-releasing Hormone Agonist Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gonadotropin-releasing Hormone Agonist Production Mode & Process
7.4 Gonadotropin-releasing Hormone Agonist Sales and Marketing
7.4.1 Gonadotropin-releasing Hormone Agonist Sales Channels
7.4.2 Gonadotropin-releasing Hormone Agonist Distributors
7.5 Gonadotropin-releasing Hormone Agonist Customers
8 GONADOTROPIN-RELEASING HORMONE AGONIST MARKET DYNAMICS
8.1 Gonadotropin-releasing Hormone Agonist Industry Trends
8.2 Gonadotropin-releasing Hormone Agonist Market Drivers
8.3 Gonadotropin-releasing Hormone Agonist Market Challenges
8.4 Gonadotropin-releasing Hormone Agonist Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Gonadotropin-releasing Hormone Agonist
1.2 Gonadotropin-releasing Hormone Agonist Segment by Type
1.2.1 Global Gonadotropin-releasing Hormone Agonist Market Value Comparison by Type (2023-2029)
1.2.2 Leuprorelin
1.2.3 Goserelin
1.2.4 Taltirelin
1.2.5 Histrelin
1.2.6 Other
1.3 Gonadotropin-releasing Hormone Agonist Segment by Application
1.3.1 Global Gonadotropin-releasing Hormone Agonist Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Gonadotropin-releasing Hormone Agonist Market Size Estimates and Forecasts
1.4.1 Global Gonadotropin-releasing Hormone Agonist Revenue 2018-2029
1.4.2 Global Gonadotropin-releasing Hormone Agonist Sales 2018-2029
1.4.3 Global Gonadotropin-releasing Hormone Agonist Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 GONADOTROPIN-RELEASING HORMONE AGONIST MARKET COMPETITION BY MANUFACTURERS
2.1 Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Manufacturers (2018-2023)
2.2 Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Gonadotropin-releasing Hormone Agonist Average Price by Manufacturers (2018-2023)
2.4 Global Gonadotropin-releasing Hormone Agonist Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist, Product Type & Application
2.7 Gonadotropin-releasing Hormone Agonist Market Competitive Situation and Trends
2.7.1 Gonadotropin-releasing Hormone Agonist Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gonadotropin-releasing Hormone Agonist Players Market Share by Revenue
2.7.3 Global Gonadotropin-releasing Hormone Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 GONADOTROPIN-RELEASING HORMONE AGONIST RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Gonadotropin-releasing Hormone Agonist Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gonadotropin-releasing Hormone Agonist Global Gonadotropin-releasing Hormone Agonist Sales by Region: 2018-2029
3.2.1 Global Gonadotropin-releasing Hormone Agonist Sales by Region: 2018-2023
3.2.2 Global Gonadotropin-releasing Hormone Agonist Sales by Region: 2024-2029
3.3 Global Gonadotropin-releasing Hormone Agonist Global Gonadotropin-releasing Hormone Agonist Revenue by Region: 2018-2029
3.3.1 Global Gonadotropin-releasing Hormone Agonist Revenue by Region: 2018-2023
3.3.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Region: 2024-2029
3.4 North America Gonadotropin-releasing Hormone Agonist Market Facts & Figures by Country
3.4.1 North America Gonadotropin-releasing Hormone Agonist Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2029)
3.4.3 North America Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gonadotropin-releasing Hormone Agonist Market Facts & Figures by Country
3.5.1 Europe Gonadotropin-releasing Hormone Agonist Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2029)
3.5.3 Europe Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gonadotropin-releasing Hormone Agonist Market Facts & Figures by Country
3.6.1 Asia Pacific Gonadotropin-releasing Hormone Agonist Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2029)
3.6.3 Asia Pacific Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gonadotropin-releasing Hormone Agonist Market Facts & Figures by Country
3.7.1 Latin America Gonadotropin-releasing Hormone Agonist Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2029)
3.7.3 Latin America Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gonadotropin-releasing Hormone Agonist Market Facts & Figures by Country
3.8.1 Middle East and Africa Gonadotropin-releasing Hormone Agonist Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Gonadotropin-releasing Hormone Agonist Sales by Type (2018-2029)
4.1.1 Global Gonadotropin-releasing Hormone Agonist Sales by Type (2018-2023)
4.1.2 Global Gonadotropin-releasing Hormone Agonist Sales by Type (2024-2029)
4.1.3 Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Type (2018-2029)
4.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Type (2018-2029)
4.2.1 Global Gonadotropin-releasing Hormone Agonist Revenue by Type (2018-2023)
4.2.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Type (2024-2029)
4.2.3 Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Type (2018-2029)
4.3 Global Gonadotropin-releasing Hormone Agonist Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Gonadotropin-releasing Hormone Agonist Sales by Application (2018-2029)
5.1.1 Global Gonadotropin-releasing Hormone Agonist Sales by Application (2018-2023)
5.1.2 Global Gonadotropin-releasing Hormone Agonist Sales by Application (2024-2029)
5.1.3 Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Application (2018-2029)
5.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Application (2018-2029)
5.2.1 Global Gonadotropin-releasing Hormone Agonist Revenue by Application (2018-2023)
5.2.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Application (2024-2029)
5.2.3 Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Application (2018-2029)
5.3 Global Gonadotropin-releasing Hormone Agonist Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Gonadotropin-releasing Hormone Agonist Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Gonadotropin-releasing Hormone Agonist Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Ferring
6.3.1 Ferring Corporation Information
6.3.2 Ferring Description and Business Overview
6.3.3 Ferring Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ferring Gonadotropin-releasing Hormone Agonist Product Portfolio
6.3.5 Ferring Recent Developments/Updates
6.4 TerSera Therapeutics
6.4.1 TerSera Therapeutics Corporation Information
6.4.2 TerSera Therapeutics Description and Business Overview
6.4.3 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.4.4 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Product Portfolio
6.4.5 TerSera Therapeutics Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Corporation Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Takeda Gonadotropin-releasing Hormone Agonist Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 LIVZON
6.6.1 LIVZON Corporation Information
6.6.2 LIVZON Description and Business Overview
6.6.3 LIVZON Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.6.4 LIVZON Gonadotropin-releasing Hormone Agonist Product Portfolio
6.6.5 LIVZON Recent Developments/Updates
6.7 Ipsen
6.6.1 Ipsen Corporation Information
6.6.2 Ipsen Description and Business Overview
6.6.3 Ipsen Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ipsen Gonadotropin-releasing Hormone Agonist Product Portfolio
6.7.5 Ipsen Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sanofi Gonadotropin-releasing Hormone Agonist Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Endo
6.9.1 Endo Corporation Information
6.9.2 Endo Description and Business Overview
6.9.3 Endo Gonadotropin-releasing Hormone Agonist Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Endo Gonadotropin-releasing Hormone Agonist Product Portfolio
6.9.5 Endo Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Gonadotropin-releasing Hormone Agonist Industry Chain Analysis
7.2 Gonadotropin-releasing Hormone Agonist Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gonadotropin-releasing Hormone Agonist Production Mode & Process
7.4 Gonadotropin-releasing Hormone Agonist Sales and Marketing
7.4.1 Gonadotropin-releasing Hormone Agonist Sales Channels
7.4.2 Gonadotropin-releasing Hormone Agonist Distributors
7.5 Gonadotropin-releasing Hormone Agonist Customers
8 GONADOTROPIN-RELEASING HORMONE AGONIST MARKET DYNAMICS
8.1 Gonadotropin-releasing Hormone Agonist Industry Trends
8.2 Gonadotropin-releasing Hormone Agonist Market Drivers
8.3 Gonadotropin-releasing Hormone Agonist Market Challenges
8.4 Gonadotropin-releasing Hormone Agonist Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Gonadotropin-releasing Hormone Agonist Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Gonadotropin-releasing Hormone Agonist Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Gonadotropin-releasing Hormone Agonist Market Competitive Situation by Manufacturers in 2022
Table 4. Global Gonadotropin-releasing Hormone Agonist Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Gonadotropin-releasing Hormone Agonist Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Gonadotropin-releasing Hormone Agonist Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Gonadotropin-releasing Hormone Agonist Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Gonadotropin-releasing Hormone Agonist, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist, Product Type & Application
Table 12. Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gonadotropin-releasing Hormone Agonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonadotropin-releasing Hormone Agonist as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gonadotropin-releasing Hormone Agonist Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Gonadotropin-releasing Hormone Agonist Sales by Region (2018-2023) & (K Units)
Table 18. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Region (2018-2023)
Table 19. Global Gonadotropin-releasing Hormone Agonist Sales by Region (2024-2029) & (K Units)
Table 20. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Region (2024-2029)
Table 21. Global Gonadotropin-releasing Hormone Agonist Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Region (2018-2023)
Table 23. Global Gonadotropin-releasing Hormone Agonist Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Region (2024-2029)
Table 25. North America Gonadotropin-releasing Hormone Agonist Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2023) & (K Units)
Table 27. North America Gonadotropin-releasing Hormone Agonist Sales by Country (2024-2029) & (K Units)
Table 28. North America Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Gonadotropin-releasing Hormone Agonist Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Gonadotropin-releasing Hormone Agonist Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2023) & (K Units)
Table 32. Europe Gonadotropin-releasing Hormone Agonist Sales by Country (2024-2029) & (K Units)
Table 33. Europe Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Gonadotropin-releasing Hormone Agonist Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Gonadotropin-releasing Hormone Agonist Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Gonadotropin-releasing Hormone Agonist Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Gonadotropin-releasing Hormone Agonist Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Gonadotropin-releasing Hormone Agonist Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Gonadotropin-releasing Hormone Agonist Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gonadotropin-releasing Hormone Agonist Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Gonadotropin-releasing Hormone Agonist Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Gonadotropin-releasing Hormone Agonist Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Gonadotropin-releasing Hormone Agonist Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Gonadotropin-releasing Hormone Agonist Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Gonadotropin-releasing Hormone Agonist Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Gonadotropin-releasing Hormone Agonist Sales (K Units) by Type (2018-2023)
Table 51. Global Gonadotropin-releasing Hormone Agonist Sales (K Units) by Type (2024-2029)
Table 52. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Type (2018-2023)
Table 53. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Type (2024-2029)
Table 54. Global Gonadotropin-releasing Hormone Agonist Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Gonadotropin-releasing Hormone Agonist Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Type (2018-2023)
Table 57. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Type (2024-2029)
Table 58. Global Gonadotropin-releasing Hormone Agonist Price (USD/Unit) by Type (2018-2023)
Table 59. Global Gonadotropin-releasing Hormone Agonist Price (USD/Unit) by Type (2024-2029)
Table 60. Global Gonadotropin-releasing Hormone Agonist Sales (K Units) by Application (2018-2023)
Table 61. Global Gonadotropin-releasing Hormone Agonist Sales (K Units) by Application (2024-2029)
Table 62. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Application (2018-2023)
Table 63. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Application (2024-2029)
Table 64. Global Gonadotropin-releasing Hormone Agonist Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Gonadotropin-releasing Hormone Agonist Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Application (2018-2023)
Table 67. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Application (2024-2029)
Table 68. Global Gonadotropin-releasing Hormone Agonist Price (USD/Unit) by Application (2018-2023)
Table 69. Global Gonadotropin-releasing Hormone Agonist Price (USD/Unit) by Application (2024-2029)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. AbbVie Gonadotropin-releasing Hormone Agonist Product
Table 74. AbbVie Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. AstraZeneca Gonadotropin-releasing Hormone Agonist Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Ferring Corporation Information
Table 81. Ferring Description and Business Overview
Table 82. Ferring Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Ferring Gonadotropin-releasing Hormone Agonist Product
Table 84. Ferring Recent Developments/Updates
Table 85. TerSera Therapeutics Corporation Information
Table 86. TerSera Therapeutics Description and Business Overview
Table 87. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Product
Table 89. TerSera Therapeutics Recent Developments/Updates
Table 90. Takeda Corporation Information
Table 91. Takeda Description and Business Overview
Table 92. Takeda Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Takeda Gonadotropin-releasing Hormone Agonist Product
Table 94. Takeda Recent Developments/Updates
Table 95. LIVZON Corporation Information
Table 96. LIVZON Description and Business Overview
Table 97. LIVZON Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. LIVZON Gonadotropin-releasing Hormone Agonist Product
Table 99. LIVZON Recent Developments/Updates
Table 100. Ipsen Corporation Information
Table 101. Ipsen Description and Business Overview
Table 102. Ipsen Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Ipsen Gonadotropin-releasing Hormone Agonist Product
Table 104. Ipsen Recent Developments/Updates
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Sanofi Gonadotropin-releasing Hormone Agonist Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Endo Corporation Information
Table 111. Endo Description and Business Overview
Table 112. Endo Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Endo Gonadotropin-releasing Hormone Agonist Product
Table 114. Endo Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Gonadotropin-releasing Hormone Agonist Distributors List
Table 118. Gonadotropin-releasing Hormone Agonist Customers List
Table 119. Gonadotropin-releasing Hormone Agonist Market Trends
Table 120. Gonadotropin-releasing Hormone Agonist Market Drivers
Table 121. Gonadotropin-releasing Hormone Agonist Market Challenges
Table 122. Gonadotropin-releasing Hormone Agonist Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 1. Global Gonadotropin-releasing Hormone Agonist Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Gonadotropin-releasing Hormone Agonist Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Gonadotropin-releasing Hormone Agonist Market Competitive Situation by Manufacturers in 2022
Table 4. Global Gonadotropin-releasing Hormone Agonist Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Gonadotropin-releasing Hormone Agonist Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Gonadotropin-releasing Hormone Agonist Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Gonadotropin-releasing Hormone Agonist Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Gonadotropin-releasing Hormone Agonist, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist, Product Type & Application
Table 12. Global Key Manufacturers of Gonadotropin-releasing Hormone Agonist, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gonadotropin-releasing Hormone Agonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonadotropin-releasing Hormone Agonist as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gonadotropin-releasing Hormone Agonist Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Gonadotropin-releasing Hormone Agonist Sales by Region (2018-2023) & (K Units)
Table 18. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Region (2018-2023)
Table 19. Global Gonadotropin-releasing Hormone Agonist Sales by Region (2024-2029) & (K Units)
Table 20. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Region (2024-2029)
Table 21. Global Gonadotropin-releasing Hormone Agonist Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Region (2018-2023)
Table 23. Global Gonadotropin-releasing Hormone Agonist Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Region (2024-2029)
Table 25. North America Gonadotropin-releasing Hormone Agonist Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2023) & (K Units)
Table 27. North America Gonadotropin-releasing Hormone Agonist Sales by Country (2024-2029) & (K Units)
Table 28. North America Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Gonadotropin-releasing Hormone Agonist Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Gonadotropin-releasing Hormone Agonist Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2023) & (K Units)
Table 32. Europe Gonadotropin-releasing Hormone Agonist Sales by Country (2024-2029) & (K Units)
Table 33. Europe Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Gonadotropin-releasing Hormone Agonist Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Gonadotropin-releasing Hormone Agonist Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Gonadotropin-releasing Hormone Agonist Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Gonadotropin-releasing Hormone Agonist Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Gonadotropin-releasing Hormone Agonist Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Gonadotropin-releasing Hormone Agonist Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gonadotropin-releasing Hormone Agonist Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Gonadotropin-releasing Hormone Agonist Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Gonadotropin-releasing Hormone Agonist Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Gonadotropin-releasing Hormone Agonist Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Gonadotropin-releasing Hormone Agonist Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Gonadotropin-releasing Hormone Agonist Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Gonadotropin-releasing Hormone Agonist Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Gonadotropin-releasing Hormone Agonist Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Gonadotropin-releasing Hormone Agonist Sales (K Units) by Type (2018-2023)
Table 51. Global Gonadotropin-releasing Hormone Agonist Sales (K Units) by Type (2024-2029)
Table 52. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Type (2018-2023)
Table 53. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Type (2024-2029)
Table 54. Global Gonadotropin-releasing Hormone Agonist Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Gonadotropin-releasing Hormone Agonist Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Type (2018-2023)
Table 57. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Type (2024-2029)
Table 58. Global Gonadotropin-releasing Hormone Agonist Price (USD/Unit) by Type (2018-2023)
Table 59. Global Gonadotropin-releasing Hormone Agonist Price (USD/Unit) by Type (2024-2029)
Table 60. Global Gonadotropin-releasing Hormone Agonist Sales (K Units) by Application (2018-2023)
Table 61. Global Gonadotropin-releasing Hormone Agonist Sales (K Units) by Application (2024-2029)
Table 62. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Application (2018-2023)
Table 63. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Application (2024-2029)
Table 64. Global Gonadotropin-releasing Hormone Agonist Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Gonadotropin-releasing Hormone Agonist Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Application (2018-2023)
Table 67. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Application (2024-2029)
Table 68. Global Gonadotropin-releasing Hormone Agonist Price (USD/Unit) by Application (2018-2023)
Table 69. Global Gonadotropin-releasing Hormone Agonist Price (USD/Unit) by Application (2024-2029)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. AbbVie Gonadotropin-releasing Hormone Agonist Product
Table 74. AbbVie Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. AstraZeneca Gonadotropin-releasing Hormone Agonist Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Ferring Corporation Information
Table 81. Ferring Description and Business Overview
Table 82. Ferring Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Ferring Gonadotropin-releasing Hormone Agonist Product
Table 84. Ferring Recent Developments/Updates
Table 85. TerSera Therapeutics Corporation Information
Table 86. TerSera Therapeutics Description and Business Overview
Table 87. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Product
Table 89. TerSera Therapeutics Recent Developments/Updates
Table 90. Takeda Corporation Information
Table 91. Takeda Description and Business Overview
Table 92. Takeda Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Takeda Gonadotropin-releasing Hormone Agonist Product
Table 94. Takeda Recent Developments/Updates
Table 95. LIVZON Corporation Information
Table 96. LIVZON Description and Business Overview
Table 97. LIVZON Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. LIVZON Gonadotropin-releasing Hormone Agonist Product
Table 99. LIVZON Recent Developments/Updates
Table 100. Ipsen Corporation Information
Table 101. Ipsen Description and Business Overview
Table 102. Ipsen Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Ipsen Gonadotropin-releasing Hormone Agonist Product
Table 104. Ipsen Recent Developments/Updates
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Sanofi Gonadotropin-releasing Hormone Agonist Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Endo Corporation Information
Table 111. Endo Description and Business Overview
Table 112. Endo Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Endo Gonadotropin-releasing Hormone Agonist Product
Table 114. Endo Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Gonadotropin-releasing Hormone Agonist Distributors List
Table 118. Gonadotropin-releasing Hormone Agonist Customers List
Table 119. Gonadotropin-releasing Hormone Agonist Market Trends
Table 120. Gonadotropin-releasing Hormone Agonist Market Drivers
Table 121. Gonadotropin-releasing Hormone Agonist Market Challenges
Table 122. Gonadotropin-releasing Hormone Agonist Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Gonadotropin-releasing Hormone Agonist
Figure 2. Global Gonadotropin-releasing Hormone Agonist Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Gonadotropin-releasing Hormone Agonist Market Share by Type in 2022 & 2029
Figure 4. Leuprorelin Product Picture
Figure 5. Goserelin Product Picture
Figure 6. Taltirelin Product Picture
Figure 7. Histrelin Product Picture
Figure 8. Other Product Picture
Figure 9. Global Gonadotropin-releasing Hormone Agonist Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Gonadotropin-releasing Hormone Agonist Market Share by Application in 2022 & 2029
Figure 11. Hospital
Figure 12. Pharmacy
Figure 13. Other
Figure 14. Global Gonadotropin-releasing Hormone Agonist Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Gonadotropin-releasing Hormone Agonist Market Size (2018-2029) & (US$ Million)
Figure 16. Global Gonadotropin-releasing Hormone Agonist Sales (2018-2029) & (K Units)
Figure 17. Global Gonadotropin-releasing Hormone Agonist Average Price (USD/Unit) & (2018-2029)
Figure 18. Gonadotropin-releasing Hormone Agonist Report Years Considered
Figure 19. Gonadotropin-releasing Hormone Agonist Sales Share by Manufacturers in 2022
Figure 20. Global Gonadotropin-releasing Hormone Agonist Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Gonadotropin-releasing Hormone Agonist Players: Market Share by Revenue in 2022
Figure 22. Gonadotropin-releasing Hormone Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Gonadotropin-releasing Hormone Agonist Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Gonadotropin-releasing Hormone Agonist Sales Market Share by Country (2018-2029)
Figure 25. North America Gonadotropin-releasing Hormone Agonist Revenue Market Share by Country (2018-2029)
Figure 26. United States Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Gonadotropin-releasing Hormone Agonist Sales Market Share by Country (2018-2029)
Figure 29. Europe Gonadotropin-releasing Hormone Agonist Revenue Market Share by Country (2018-2029)
Figure 30. Germany Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Gonadotropin-releasing Hormone Agonist Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Gonadotropin-releasing Hormone Agonist Revenue Market Share by Region (2018-2029)
Figure 37. China Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Gonadotropin-releasing Hormone Agonist Sales Market Share by Country (2018-2029)
Figure 47. Latin America Gonadotropin-releasing Hormone Agonist Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Gonadotropin-releasing Hormone Agonist Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Gonadotropin-releasing Hormone Agonist Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Gonadotropin-releasing Hormone Agonist by Type (2018-2029)
Figure 57. Global Revenue Market Share of Gonadotropin-releasing Hormone Agonist by Type (2018-2029)
Figure 58. Global Gonadotropin-releasing Hormone Agonist Price (USD/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Gonadotropin-releasing Hormone Agonist by Application (2018-2029)
Figure 60. Global Revenue Market Share of Gonadotropin-releasing Hormone Agonist by Application (2018-2029)
Figure 61. Global Gonadotropin-releasing Hormone Agonist Price (USD/Unit) by Application (2018-2029)
Figure 62. Gonadotropin-releasing Hormone Agonist Value Chain
Figure 63. Gonadotropin-releasing Hormone Agonist Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Figure 1. Product Picture of Gonadotropin-releasing Hormone Agonist
Figure 2. Global Gonadotropin-releasing Hormone Agonist Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Gonadotropin-releasing Hormone Agonist Market Share by Type in 2022 & 2029
Figure 4. Leuprorelin Product Picture
Figure 5. Goserelin Product Picture
Figure 6. Taltirelin Product Picture
Figure 7. Histrelin Product Picture
Figure 8. Other Product Picture
Figure 9. Global Gonadotropin-releasing Hormone Agonist Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Gonadotropin-releasing Hormone Agonist Market Share by Application in 2022 & 2029
Figure 11. Hospital
Figure 12. Pharmacy
Figure 13. Other
Figure 14. Global Gonadotropin-releasing Hormone Agonist Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Gonadotropin-releasing Hormone Agonist Market Size (2018-2029) & (US$ Million)
Figure 16. Global Gonadotropin-releasing Hormone Agonist Sales (2018-2029) & (K Units)
Figure 17. Global Gonadotropin-releasing Hormone Agonist Average Price (USD/Unit) & (2018-2029)
Figure 18. Gonadotropin-releasing Hormone Agonist Report Years Considered
Figure 19. Gonadotropin-releasing Hormone Agonist Sales Share by Manufacturers in 2022
Figure 20. Global Gonadotropin-releasing Hormone Agonist Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Gonadotropin-releasing Hormone Agonist Players: Market Share by Revenue in 2022
Figure 22. Gonadotropin-releasing Hormone Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Gonadotropin-releasing Hormone Agonist Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Gonadotropin-releasing Hormone Agonist Sales Market Share by Country (2018-2029)
Figure 25. North America Gonadotropin-releasing Hormone Agonist Revenue Market Share by Country (2018-2029)
Figure 26. United States Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Gonadotropin-releasing Hormone Agonist Sales Market Share by Country (2018-2029)
Figure 29. Europe Gonadotropin-releasing Hormone Agonist Revenue Market Share by Country (2018-2029)
Figure 30. Germany Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Gonadotropin-releasing Hormone Agonist Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Gonadotropin-releasing Hormone Agonist Revenue Market Share by Region (2018-2029)
Figure 37. China Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Gonadotropin-releasing Hormone Agonist Sales Market Share by Country (2018-2029)
Figure 47. Latin America Gonadotropin-releasing Hormone Agonist Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Gonadotropin-releasing Hormone Agonist Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Gonadotropin-releasing Hormone Agonist Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Gonadotropin-releasing Hormone Agonist Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Gonadotropin-releasing Hormone Agonist by Type (2018-2029)
Figure 57. Global Revenue Market Share of Gonadotropin-releasing Hormone Agonist by Type (2018-2029)
Figure 58. Global Gonadotropin-releasing Hormone Agonist Price (USD/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Gonadotropin-releasing Hormone Agonist by Application (2018-2029)
Figure 60. Global Revenue Market Share of Gonadotropin-releasing Hormone Agonist by Application (2018-2029)
Figure 61. Global Gonadotropin-releasing Hormone Agonist Price (USD/Unit) by Application (2018-2029)
Figure 62. Gonadotropin-releasing Hormone Agonist Value Chain
Figure 63. Gonadotropin-releasing Hormone Agonist Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
